Tarsus Announces Pricing of Upsized $125.0 Million Public Offering
Portfolio Pulse from
Tarsus Pharmaceuticals has announced the pricing of an upsized public offering, raising approximately $125 million by selling 2,808,988 shares at $44.50 each. The offering is expected to close on March 14, 2025.
March 13, 2025 | 2:00 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Tarsus Pharmaceuticals has priced an upsized public offering of 2,808,988 shares at $44.50 per share, aiming to raise $125 million. The offering is set to close on March 14, 2025.
The public offering is a significant equity action for Tarsus Pharmaceuticals, potentially impacting its stock price. However, the impact on the stock price is uncertain in the short term as it depends on market reception and the use of proceeds.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100